BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Acetaminophen
,
rs6983267
,
CXCL2
,
T cell differentiation
,
Obesity
,
Lung
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TCR] genes
Summary
General Info
Curated Studies
Most Correlated Studies
The Immunological Genome Project - Immune cell lineage differentiation and maturation
CD4+ T cells with IL2 knockout expressing OVA specific TCR and stimulated with OVA
Role of PKD2 in TCR-induced transcriptional reprogramming of naïve T cells
CD8+ T cells transgenic for OT-I TCR from mice infected with ovalbumin-expressing L. monocytogenes
CD4-positive T cells and antigen presenting cells from OVA TCR mice treated with abatacept
Explore Curated Studies Results
Literature
Most Relevant Literature
Immunoglobulin/T-Cell Receptor Gene Rearrangement Analysis Using RNA-Seq.
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer.
T-cell Receptor Gene Therapy Clinically Targeting a TP53 Public Neoantigen.
Ruxolitinib for Refractory PL-12 Antisynthetase Syndrome-Associated Angioedema-Like Panniculitis Wit…
The Legend of Delta: Finding a New TCR Gene.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Non-Viral TCR Gene Therapy
Clinical Safety and Preliminary Efficacy of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tum…
Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Follow…
Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR G…
MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ